[Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
Ohlsson
Ola
O
Medicinska kliniken, Centralsjukhuset, Kristianstad. ola.b.ohlsson@skane.se
D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D032921:Consensus; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D013548:Sweden
D000959:Antihypertensive Agents